China Shineway Pharmaceutical Group Ltd
02877
Company Profile
Business description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
Contact
Luan Cheng
Hebei Province
Shijiazhuang
CHNT: +86 18420027587
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
3,220
Stocks News & Analysis
stocks
Another incredible quarter from Microsoft
We were wrong when we thought last quarter would be hard to top.
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks
Leading ASX players in this field look materially overvalued
We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,929.50 | 69.50 | -0.77% |
| CAC 40 | 7,771.97 | 89.99 | -1.14% |
| DAX 40 | 24,065.47 | 196.75 | -0.81% |
| Dow JONES (US) | 44,130.98 | 330.30 | -0.74% |
| FTSE 100 | 9,132.81 | 4.13 | -0.05% |
| HKSE | 24,771.26 | 2.07 | -0.01% |
| NASDAQ | 21,122.45 | 7.23 | -0.03% |
| Nikkei 225 | 40,885.56 | 184.26 | -0.45% |
| NZX 50 Index | 12,751.03 | 72.71 | -0.57% |
| S&P 500 | 6,339.39 | 23.51 | -0.37% |
| S&P/ASX 200 | 8,676.20 | 66.60 | -0.76% |
| SSE Composite Index | 3,568.26 | 4.95 | -0.14% |